h1n1

Walgreen Company Reports a Not-So-Compelling Second Quarter

Posted on March 23rd, 2010 in CVS, CVS Caremark, CvsCaremark, drugstore, h1n1, India Shares, RAD, retail, Rite Aid, RiteAid, wag, Wal-Mart, Walgreen, wmt

Filed under: , , , ,

Walgreen Company (WAG), a drugstore entity whose major competitors are CVS Caremark (CVS), Rite Aid (RAD), and Wal-Mart Stores, Inc. (WMT), reported second-quarter data earlier today; they weren’t too thrilling, to be completely honest.

On a reported basis, net income increased three pennies to 68 cents per share. On an adjusted basis, earnings came out to 70 cents per share (this would be after adding back the two pennies dedicated to restructuring charges). Estimates called for 71 cents per share. Poor Walgreen just couldn’t keep up with the analysts this time around.

Continue reading Walgreen Company Reports a Not-So-Compelling Second Quarter

Walgreen Company Reports a Not-So-Compelling Second Quarter originally appeared on BloggingStocks on Tue, 23 Mar 2010 16:20:00 EST. Please see our terms for use of feeds.

Read | Permalink | Email this | Comments

Add to digg
Add to del.icio.us
Add to Google
Add to StumbleUpon
Add to Facebook
Add to Reddit
Add to Technorati


Tags: ,
Read post Add your comment

Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts

Posted on December 04th, 2009 in h1n1, India Shares, SAGE, Swine Flu

The Strategic Advisory Group of Experts (SAGE) on immunization reports to the Director-General of WHO on issues ranging from vaccine research and development to immunization delivery. Its remit extends beyond childhood immunization to all vaccine-preventable diseases.1 SAGE met on 27–29 October 2009 in Geneva, Switzerland.2 The following are SAGE’s conclusions and recommendations on pandemic influenza A (H1N1) 2009 virus vaccine. Conclusions and recommendations related to other topics discussed at the meeting will be published in the Weekly Epidemiological Record on 11 December 2009.

Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts is a post from: First Blog for Indian Financial Market

Tags: ,
Read post Add your comment

Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts

Posted on December 04th, 2009 in h1n1, India Shares, SAGE, Swine Flu

The Strategic Advisory Group of Experts (SAGE) on immunization reports to the Director-General of WHO on issues ranging from vaccine research and development to immunization delivery. Its remit extends beyond childhood immunization to all vaccine-preventable diseases.1 SAGE met on 27–29 October 2009 in Geneva, Switzerland.2 The following are SAGE’s conclusions and recommendations on pandemic influenza A (H1N1) 2009 virus vaccine. Conclusions and recommendations related to other topics discussed at the meeting will be published in the Weekly Epidemiological Record on 11 December 2009.

Pandemic influenza A (H1N1) 2009 virus vaccine – conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts is a post from: First Blog for Indian Financial Market

Tags: ,
Read post Add your comment

Pandemic (H1N1) 2009 – update 77

Posted on December 04th, 2009 in h1n1, India Shares, Swine Flu

As of 29 November 2009, worldwide more than 207 countries and overseas territories or communities have reported laboratory confirmed cases of pandemic influenza H1N1 2009, including at least 8768 deaths.

Pandemic (H1N1) 2009 – update 77 is a post from: First Blog for Indian Financial Market

Tags: ,
Read post Add your comment
Older posts »